Financing & Review - In February 2026, the Beijing Stock Exchange (BSE) issued 6 new stocks, raising a total of 1.635 billion yuan; the cumulative amount raised in January-February 2026 reached 3.414 billion yuan[5] - The average review cycle for companies was 251 days, with 6 companies passing the review and 2 terminating their applications[5] Subscription & Issuance - The median first-day price increase for the 3 new stocks listed in February was +142.31%, with individual increases of +202.96%, +142.31%, and +82.12% for Ai De Technology, Hai Sheng Medical, and Tong Bao Optoelectronics respectively[3] - The cumulative subscription yield for new stocks in January-February 2026 was +0.53%, while the total yield for 2025 was +3.31%[3] New Stock Subscription Yield & Rate Predictions - The expected total number of new stock issuances for 2026 has been raised to 50, with a total fundraising target of 14.375 billion yuan[5] - The median first-day increase for directly priced new stocks is projected at 250%, with various scenarios considered[5] Investment Analysis - The BSE is accelerating new stock issuance, with 11 new stocks issued in January-February 2026, nearing half of the total issuance for the previous year[5] - The report highlights a significant reduction in individual stock returns due to increased initial valuations, with the average price-earnings ratio for newly issued stocks at 14.99 times[5] Risk Factors - Potential risks include slower-than-expected issuance rates, lower-than-expected stock price increases, changes in the BSE's issuance system, and rapid growth in new stock subscription accounts[5]
2026年北交所新股申购2月报：网上申购薄利多销，上调全年新股发行数量-20260303